Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
AACL AACL AACL AACL
BSAAM Logo
AACL Logo
Anti Ageing Conference London 2020
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Register Info
   
Delegate Information
   
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
   
Past Conference Information
  2018
2018 Speakers and Presentations
2018 Programme
2018 Exhibitors

BSAAMs AACL 2018 Peer Review Board Members
  2017
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
  2016
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
  2015
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
  2014
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
  2013
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
  2012
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
  2011
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
  2010
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
  2009
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
  2008
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  2006
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  2005
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  2004
  Past Speakers 2004
  2002
  Past Speakers Monte Carlo 2002
   
BSAAM's AACL Organizer
BSAAM
BSAAM Affiliates
waaam
   
   
A4M
   
wosaam
AACL Supporters
HB Health
www.hbhealth.com
   
CPD
   
  BANT
   
 
   
 
   
  Sun Chlorella
   
 
   
enerzona
   
BHMA
   
WOCPM
   
FACE
   
IAAS
   
Dole
   
 
   
 
   
   

AACL 2012 Speaker

Masud HaqDr Masud Haq BSc (Hons), MBBS (Hons), MRCP, MD

Dr Masud Haq is a Consultant Physician in Diabetes & Endocrinology at Kent & Sussex Hospital, Royal Tunbridge Wells, and a former graduate of Guy’s & St.Thomas’s Hospital, London. As a trainee he studied HIV & chest medicine at Johns Hopkins Medical School, USA, and modern vascular surgical techniques at St.Vincent’s Hospital, Melbourne, Australia. He completed a Bachelor Degree in Biochemistry assessing novel cardiovascular risk markers and was awarded a Wellcome Scholarship. He later completed a Doctorate in Medicine at the Royal Marsden Hospital studying the effects of radioiodine dosimetry treatment in patients affected by thyroid cancer. His work has been presented at numerous international meetings and was shortlisted for the European Marie Curie prize in 2007.

A former Consultant at St.George’s Hospital and Chelsea & Westminster NHS Foundation Trust, Dr Haq presently is a member of West Kent Diabetes Clinical Advisory Panel, Diabetes UK, The British Thyroid Association and UK Society of Endocrinologists. His main interests lie in thyroid disease and endocrine effects seen in ageing.

2012 - Injectable GLP-1 therapy - weight loss effects seen in obesity with and without type 2 diabetes

Recent advances in the understanding of peptide signalling of hunger and satiety from the gastrointestinal tract have opened new possible therapeutic targets to treat obesity. Various peptides have been studied and include ghrelin, cholecystokinin (CCK), peptide tyrosine-tyrosine (PYY) and glucagon-like peptide-1 (GLP-1), and homeostatic mechanisms related to leptin.

GLP-1 is a prohormone that is produced from gastrointestinal tract in response to ingestion of food and results in insulin release in a glucose-dependant manner, inhibition of glucagon secretion, delayed gastric emptying and suppression of the appetite centre in the brain. Numerous clinical studies have demonstrated the effectiveness of injectable GLP-1 analogues in the treatment of patients with type 2 diabetes resulting in improved glycaemic control and weight loss. This group of drugs has also proven to be successful in promoting weight loss in obese non-diabetic subjects.

A review of this subject together with clinical results will be presented.

 

Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :
london@antiageingconference.com
mariasomers@bsaam.com